Symbol: |
NEUROG3
|
Description: |
neurogenin 3 [Source:HGNC Symbol;Acc:13806]
|
Location: |
Chr10:71331454-71332994[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:243
Gene |
Compound |
Gen_sig |
Exp_pattern |
NEUROG3 |
NSC 109834 |
0.025 |
Down |
NEUROG3 |
NSC 119911 |
0.018 |
Down |
NEUROG3 |
NSC 119915 |
0.016 |
Down |
NEUROG3 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.004 |
Down |
NEUROG3 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.049 |
Down |
NEUROG3 |
VERNOLIDE |
0.025 |
Down |
NEUROG3 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.006 |
Down |
NEUROG3 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.03 |
Down |
NEUROG3 |
NSC 135371 |
0.038 |
Down |
NEUROG3 |
NSC 13713 |
0.045 |
Down |
NEUROG3 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.006 |
Down |
NEUROG3 |
TZT |
0.006 |
Down |
NEUROG3 |
NSC 166382 |
0.01 |
Down |
NEUROG3 |
NSC 168197 |
0.007 |
Down |
NEUROG3 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.045 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:30
Total:2 Current:1
[First] [Prev]  Next Last 
|